1. Opioid use in Medicare Part D remains concerning Publication: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, June 2018 Subject(s): Analgesics, Opioid -- therapeutic useMedicare Part DOpioid-Related Disorders -- epidemiologyPrescription Drug MisuseAnalgesics, Opioid -- economicsFentanyl -- adverse effectsPrescription Drug DiversionHumansUnited StatesUnited States. Department of Health and Human Services.
2. Opioids in Ohio Medicaid: review of extreme use and prescribing Publication: [Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, July 2018 Subject(s): Analgesics, Opioid -- therapeutic useInappropriate PrescribingMedicaidOpioid-Related Disorders -- epidemiologyOpioid-Related Disorders -- prevention & controlPrescription Drug MisuseAnalgesics, Opioid -- administration & dosageHumansOhioUnited StatesUnited States. Department of Health and Human Services.Centers for Medicare & Medicaid Services (U.S.)
3. Prescription opioids: Medicare needs to expand oversight efforts to reduce the risk of harm : report to Congressional requesters Publication: Washington, DC : United States Government Accountability Office, October 2017 Subject(s): Analgesics, Opioid -- therapeutic useDrug Utilization ReviewGovernment RegulationInappropriate PrescribingMedicare Part DPrescription Drug MisuseFraud -- prevention & controlOpioid-Related DisordersHumansUnited StatesCenters for Medicare & Medicaid Services (U.S.)
